A genetic polymorphism in SLCO1B1, c.521T>C (rs4149056), is associated with a significant reduction in transporter activity [72], with significantly lower LDL-C reductions and a higher risk of myopathy, especially in homozygous patients [73]. This evidence concerns the gene SLCO1B1 and myopathy.